Progyny (NASDAQ:PGNY) Shares Up 3.3% – What’s Next?

Progyny, Inc. (NASDAQ:PGNY)’s share price shot up 3.3% on Monday . The stock traded as high as $22.66 and last traded at $22.62. 145,917 shares changed hands during trading, a decline of 91% from the average session volume of 1,690,619 shares. The stock had previously closed at $21.90.

Wall Street Analyst Weigh In

PGNY has been the subject of several research reports. Bank of America upped their target price on shares of Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. JPMorgan Chase & Co. lifted their target price on shares of Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 28th. Canaccord Genuity Group upped their price target on shares of Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research report on Friday, February 28th. Finally, BTIG Research raised Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price objective on the stock in a research note on Monday. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $23.64.

Progyny Price Performance

The stock has a market capitalization of $1.92 billion, a PE ratio of 38.75, a PEG ratio of 2.39 and a beta of 1.41. The company has a 50 day moving average price of $22.06 and a 200-day moving average price of $18.50.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in PGNY. Leibman Financial Services Inc. boosted its stake in shares of Progyny by 100.7% during the 4th quarter. Leibman Financial Services Inc. now owns 63,509 shares of the company’s stock valued at $1,096,000 after purchasing an additional 31,872 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in Progyny by 90.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company’s stock worth $25,319,000 after buying an additional 695,740 shares during the period. Clear Harbor Asset Management LLC bought a new stake in Progyny during the 4th quarter valued at approximately $989,000. Barclays PLC grew its holdings in shares of Progyny by 530.4% during the 3rd quarter. Barclays PLC now owns 706,157 shares of the company’s stock worth $11,835,000 after acquiring an additional 594,140 shares during the period. Finally, Baillie Gifford & Co. raised its position in shares of Progyny by 52.2% in the 4th quarter. Baillie Gifford & Co. now owns 1,332,690 shares of the company’s stock worth $22,989,000 after acquiring an additional 456,853 shares in the last quarter. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.